Tuesday, February 9, 2010, 11:30pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

NeurogesX, Inc. (NGSX)

At 16:00 EST: 7.31 USD  Up 0.13 (1.81%)  
MORE ON NGSX
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Thu, Feb 4, 2010
NEUROGESX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Thu, Feb 4)
NeurogesX to Present at BIO CEO & Investor Conference
PRNewswire (Thu, Feb 4)
NeurogesX CFO names on COO role as well
at bizjournals.com (Thu, Feb 4)
NeurogesX Announces Management Team Promotions
PRNewswire (Thu, Feb 4)
Mon, Feb 1, 2010
[video] Trading Smallcap Biotech
at TheStreet.com (Mon, Feb 1)
Thu, Jan 21, 2010
NEUROGESX INC Files SEC form 8-K/A, Change in Directors or Principal Officers
EDGAR Online (Thu, Jan 21)
Thu, Jan 14, 2010
NEUROGESX INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Thu, Jan 14)
Thu, Jan 7, 2010
NeurogesX to Present at J.P. Morgan Health Care Conference
PRNewswire (Thu, Jan 7)
Tue, Nov 24, 2009
NeurogesX to Present at Piper Jaffray Health Care Conference
PRNewswire (Tue, Nov 24)
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
PRNewswire (Tue, Nov 24)
Tue, Nov 17, 2009
[$$] Pacific Sunwear and Sunpower Fall
at The Wall Street Journal Online (Tue, Nov 17)
NEUROGESX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
NeurogesX shares rise following FDA approval
AP (Tue, Nov 17)
NeurogesX to Hold Conference Call to Discuss FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN) Conferenc
PRNewswire (Tue, Nov 17)
Mon, Nov 16, 2009
NeurogesX wins FDA OK for pain treatment Qutenza
at MarketWatch (Mon, Nov 16)
NeurogesX pain patch gets FDA OK
at bizjournals.com (Mon, Nov 16)
NeurogesX gets FDA approval for pain patch
AP (Mon, Nov 16)
NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN) First and only prescription strengt
PRNewswire (Mon, Nov 16)
Fri, Nov 13, 2009
NEUROGESX INC Financials
EDGAR Online Financials (Fri, Nov 13)
Tue, Nov 10, 2009
3 Companies Looking for Gratitude Early
at Motley Fool (Tue, Nov 10)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices